Lung Cancer

NSCLC of Upper Lobe of Right Lung

Male, 68 years

Patient Internal ID: 275816445

ICD-10 code

C45.0 Mesothelioma of Pleura

Diagnosis (Incl. Metastases/Stage) and Year

January 2020
Non-Small Cell Lung Carcinoma of the Upper Lobe of the Right Lung cT4N3M1 Stage IVb EGFR+. Metastases in the Left Lung, Abdominal Lymph Nodes, Liver, Adrenal Glands, Brain and Bones.

Previous Treatment

Target Therapy (Afatinib), Radiation Therapy, Gama Knife, Chemotherapy (Cisplatin and Pemetrexed), Chemotherapy (Docetaxel and Nintedanib).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of 16 months and the 5-year relative survival rate is about 9%.

Treatment Provided

Autologous DCV (6 doses) and CIK (4 doses) over a period of 4 months.

Patient Survival/Condition and Year
Date of Review: 15/10/2023

The patient has survived for 22 months. It can be concluded that the addition of Immunotherapy, alongside Target therapy, Radiation Therapy and Chemotherapy, has extended patient survival by an estimate of 8 months.